Revive Therapeutics Ltd (RVVTF)

[Ecomike]

There seems to be a lot of empirical evidence of this, since Covid19...And the Need for FDA approval of $RVVTF Bucillamine gets more obvious everyday,

This explains much.

https://scitechdaily.com/covid-19-strikes-again-accelerating-dementia-in-the-most-vulnerable/

All subtypes of dementia, irrespective of patients’ previous dementia types, behaved like rapidly progressive dementia following COVID-19, according to the Journal of Alzheimer’s Disease Reports

Infection with SARS-CoV-2 has a significant impact on cognitive function in patients with preexisting dementia, according to new research, published in the Journal of Alzheimer’s Disease Reports. Patients with all subtypes of dementia included in the study experienced rapidly progressive dementia following infection with SARS-CoV-2.

Since the first wave of COVID-19, neurologists have noticed both acute and long-term neurological syndromes and neuropsychiatric sequelae of this infectious disease. Insights into the impact of COVID-19 on human cognition has so far remained unclear, with neurologists referring to “brain fog.” A group of researchers driven to gain a better understanding of and dissipate this fog investigated the effects of COVID-19 on cognitive impairment in 14 patients with preexisting dementia (four with Alzheimer’s disease [AD], five with vascular dementia, three with Parkinson’s disease dementia, and two with the behavioral variant of frontotemporal dementia), who had suffered further cognitive deterioration following COVID-19.

https://www.goodrx.com/conditions/dementia/these-drugs-could-increase-your-risk-of-dementia

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1527-3466.2003.tb00107.x

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846521/